Combining Immunotherapy with Isolated Limb Infusion in Treating Advanced Melanoma

VIDEO | 03:00

Surgical oncologist Charlotte Ariyan explains the standard treatment strategy for patients diagnosed with early melanoma, which can include surgical removal of the cancer.
Dr. Ariyan explains how she is leading a clinical trial with surgical oncologist Mary Sue Brady of a new treatment approach for patients with advanced disease, which combines chemotherapy and an immune system drug therapy. First, patients receive chemotherapy to an affected limb through a minimally invasive procedure known as an isolated limb infusion. Next, they receive a US Food and Drug Administration–approved immunotherapy treatment called ipilimumab (Yervoy ™).
Learn more about this clinical trial.